In summary, we found that Wnt5a induces ROR1 to recruit and activate DOCK2, leading to activation of ERK1/2, which appears responsible for the capacity of Wnt5a to enhance leukemia-cell proliferation. This evidence concerns the gene DOCK2 and leukemia.